azomycin has been researched along with Exanthema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsuaga, M; Balas, A; Bellón, T; Cabañas, R; de Abajo, F; Fiandor, A; Herranz, P; Lerma, V; LuisVicario, J; Ramírez, E; Sanz, B; Trigo, E | 1 |
| Bamberg, M; Scherer, E; Streffer, C; Tamulevicius, P | 1 |
2 other study(ies) available for azomycin and Exanthema
| Article | Year |
|---|---|
HLA-A∗68, -A∗11:01, and -A∗29:02 alleles are strongly associated with benznidazole-induced maculopapular exanthema (MPE)/DRESS.
Topics: Alleles; Anticonvulsants; Exanthema; HLA-A Antigens; Humans; Nitroimidazoles | 2020 |
[Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dexamethasone; Drug Interactions; Esophageal Neoplasms; Exanthema; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Phenytoin | 1981 |